Relypsa Announces Phase 2 Data Showing Efficacy of Patiromer FOS in Heart Failure Patients With Chronic Kidney Disease at ACC Scientific Session – Sub-group Analysis of AMETHYST-DN Trial Results Led by Bertram Pitt, M.D. – Sponsored Panel at ACC Led by...
Truveris Launches Pharmacy Stop Loss Insurance Platform to Protect Employers from Rising Benefit Costs Brokers and Advisors Can Now Run Stop Loss Quotes in Minutes Using the RxChoice® Self-Service Marketplace NEW YORK, NY – March 17, 2015 – With employers...
CardioKinetix Announces Excellent Results of Chinese Trial Evaluating Parachute Heart Failure Device Menlo Park, Calif. and Beijing, China — March 24, 2015 — CardioKinetix Inc., a medical device company pioneering a catheter-based treatment for heart failure, today...
Oxford Immunotec Announces Availability of the T-SPOT.CMV Test in the United States OXFORD, UK and MARLBOROUGH, MA, March 31, 2015 (GLOBE NEWSWIRE) – Oxford Immunotec Global PLC (Nasdaq: OXFD), a global, commercial-stage diagnostics company focused on developing and...
Advanced Cell Diagnostics Completes $22 Million Series C Equity Financing Proceeds Will Accelerate Commercialization and Launch of New Technology Platforms Hayward, CA – June 18, 2015 – Advanced Cell Diagnostics, Inc. (ACD), a world leader in the field of in situ...
Recent Comments